Drug intelligence / Profile preview

[68Ga]Ga-NOTA-RD06

Development stage
Phase 2
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[68Ga]Ga-NOTA-RD06 is a radiopharmaceutical designed for Positron Emission Tomography (PET) imaging. It consists of the radioisotope Gallium-68 ([68Ga]), which is a positron emitter, chelated by 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA). The 'RD06' component is presumed to be a targeting moiety, but its specific identity, biological target, and mechanism of action are not clearly defined or publicly documented in available scientific literature. Radiopharmaceuticals like this are generally used as diagnostic agents to visualize specific biological processes or disease markers in vivo. The Gallium-68 allows for detection via PET scanning, while the NOTA chelator stably binds the radioisotope to the targeting molecule. The specific function of the 'RD06' component would dictate the primary indication and the biological target of this particular radiopharmaceutical, but this information is currently unavailable.

Other names
[68Ga]Ga-NOTA-RD06[68Ga]RD06Ga-68 NOTA-RD06Ga68 NOTA-RD06Ga 68 NOTA-RD06
02

Targets

CD70 (Cluster of Differentiation 70)

Beyond the preview

Go deeper on [68Ga]Ga-NOTA-RD06.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-NOTA-RD06.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call